Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.
|Journal||Clinical Chemistry (Washington, DC)|
|Number of pages||12|
|Publication status||Published - 1 Oct 2010|